The Automated Medical Yeoman (AMY) is a urinalysis device that aims to revolutionize the way we approach active health monitoring. The Principal Investigator, Amy Johns, first received recognition for the AMY through a NASA-funded workforce development program for undergraduate students and aspiring new professionals. With the seed funding to create a revoluntary new piece of technology, the Esperance team is developing the AMY beyond the conceptual realm and into a functional device ready for spaceflight and commercialization.
Esperance is currently expanding our team with volunteer industry professionals, graduates, and undergraduates located in the United States. If you would like to volunteer to be part of history by contributing to the AMY, please apply through our applications page